Cantitate/Preț
Produs

Combinational Therapy in Triple Negative Breast Cancer

Autor Manzoor Ahmad Mir
en Limba Engleză Paperback – 5 mai 2022
Combinational Therapy in Triple Negative Breast Cancer discusses TNBC at the molecular level from a holistic approach, focusing on combinational strategies targeting various pathways involved in this specific cancer type. Using a monotherapy for the treatment of cancer, especially high-grade tumors like TNBC, is mostly worthless due to the inherent genetic instability of tumor cells to develop intrinsic and acquired resistance. Combination therapy presents more, or at least the same, effectiveness with lower doses of every single agent and decreases the likelihood of chemoresistance, making it essential to understand for multiple therapy options.
The book is a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of combinational therapies to treat triple negative breast cancer.


  • Presents up-to-date and cutting-edge knowledge of Triple negative breast cancer (TNBC) biology, clinical aspects and treatment options
  • Discusses novel targets and pathways involved in TNBC
  • Provides insights and approaches for future research on TNBC
Citește tot Restrânge

Preț: 62600 lei

Nou

Puncte Express: 939

Preț estimativ în valută:
11984 12457$ 9936£

Carte disponibilă

Livrare economică 15-29 ianuarie 25
Livrare express 31 decembrie 24 - 04 ianuarie 25 pentru 3518 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323961363
ISBN-10: 0323961363
Pagini: 276
Dimensiuni: 191 x 235 x 19 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE

Public țintă

Researchers and graduate students on cancer research
Oncologists, medical doctors

Cuprins

1. TNBC: an aggressive subtype of breast cancer2. Novel Biomarkers and Genetics: Role and Perspective3. Current Therapeutics and Treatment: Significance and controversies4. Conventional Adjuvant Chemotherapy in combination with Surgery, Radiotherapy and other non-specific agents5. Role of Immune system in Oncometastasis: A New Perspective6. What if immunotherapy is used in combination with the chemotherapy?7. Will there be any improvement if chemotherapy is combined with target specific biological agents?8. Different drug delivery Approaches in combinational Therapy